Fractyl Health (GUTS) Other Gross PP&E Adjustments (2023 - 2026)
Fractyl Health (GUTS) reported Other Gross PP&E Adjustments of -$27.1 million for Q1 2026, up 6.6% year-on-year from -$25.4 million in Q1 2025, and down 20.81% quarter-over-quarter from -$22.4 million in Q4 2025.
Fractyl Health (GUTS) has 4 years of Other Gross PP&E Adjustments data on file, last reported at -$27.1 million in Q1 2026.
- For the quarter ending Q1 2026, Other Gross PP&E Adjustments rose 6.6% year-over-year to -$27.1 million; the trailing twelve-month figure through Mar 2026 stood at -$27.1 million (up 6.6% YoY), and the FY2025 full-year result was -$22.4 million, up 10.7% from the prior year.
- Other Gross PP&E Adjustments for Q1 2026 stood at -$27.1 million, down from -$22.4 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$22.4 million in Q4 2025 and bottomed at -$30.6 million in Q1 2024.
- A 4-year average of -$27.8 million and a median of -$28.7 million in 2025 frame the typical range for Other Gross PP&E Adjustments.
- Peak annual rise in Other Gross PP&E Adjustments reached 10.7% in 2025, while the deepest fall reached 2.31% in 2025.
- Tracing GUTS's Other Gross PP&E Adjustments over 4 years: stood at -$27.2 million in 2023, then climbed by 7.65% to -$25.1 million in 2024, then grew by 10.7% to -$22.4 million in 2025, then retreated by 20.81% to -$27.1 million in 2026.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods registered -$27.1 million, -$22.4 million, and -$28.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - | -27.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.08 Mn |
| Mar 31, 2026 | -27.08 Mn |
| Dec 31, 2025 | -22.42 Mn |
| Dec 31, 2025 | -22.42 Mn |
| Sep 30, 2025 | -28.78 Mn |
| Sep 30, 2025 | -28.78 Mn |
| Jun 30, 2025 | -28.55 Mn |
| Jun 30, 2025 | -28.55 Mn |
| Mar 31, 2025 | -29.00 Mn |
| Mar 31, 2025 | -29.00 Mn |
| Dec 31, 2024 | -25.10 Mn |
| Dec 31, 2024 | -25.10 Mn |
| Sep 30, 2024 | -29.46 Mn |
| Sep 30, 2024 | -29.46 Mn |
| Jun 30, 2024 | -29.85 Mn |
| Jun 30, 2024 | -29.85 Mn |
| Mar 31, 2024 | -30.58 Mn |
| Mar 31, 2024 | -30.58 Mn |
| Dec 31, 2023 | -27.18 Mn |
| Dec 31, 2023 | -27.18 Mn |